Prescriber is the leading UK journal for healthcare professionals focussing on prescribing and medicines management. The journal features articles on all areas of therapeutics and prescribing policy and is fully peer reviewed. The content is relevant and of interest to all prescribers and prescribing policy makers including GPs, pharmacists, nurses and hospital specialists. Access to all content is free to healthcare professionals following registration.Sign up for e-alerts and print copies

Latest News

Cladribine granted licence in the UK and Ireland

Cladribine (Mavenclad) has been licensed in the UK and Ireland for the treatment of adult patients with highly active and relapsing multiple sclerosis (MS)....Read more

NICE approves dimethyl fumarate for plaque psoriasis

In final technology appraisal guidance (TA475), NICE has recommended dimethyl fumarate (Skilarence) as an option for the treatment of plaque psoriasis in...Read more

NICE publishes first guideline on endometriosis

NICE has published its first guideline on the diagnosis and management of endometriosis (NG73). The guideline aims to raise awareness of the symptoms of...Read more

NHS England expands international recruitment of GPs

NHS England has announced a major increase to the GP workforce through the introduction of an international recruitment programme, following a series of...Read more

Rivaroxaban can reduce the risk of cardiovascular death and stroke

The anticoagulant drug rivaroxaban (Xarelto) can significantly reduce the risk of cardiovascular death and stroke when used in combination with aspirin as the...Read more

Featured Articles

The continuing challenges of improving men’s health
Cardiovascular disease, liver disease, colon cancer, erectile dysfunction and coronary artery disease were among the areas discussed during the latest Men’s Health Conference held at the Royal Society of Medicine in June.
Click here to view

Managing diabetes in the presence of renal impairment
Chronic kidney disease is common in patients with diabetes and is associated with increased morbidity and mortality. This article discusses the challenges of maintaining good glycaemic control and addressing modifiable risk factors in patients with diabetes and renal impairment.
Click here to view

Oral anticoagulants for stroke prevention in nonvalvular AF
Warfarin and direct oral anticoagulants (DOACs) have been shown to reduce the risk of stroke in patients with atrial fibrillation, yet many patients are still not being anticoagulated. This article discusses the barriers to the initiation of oral anticoagulants, in particular DOACs, and how these can be overcome.
Click here to view

Web design and marketing agency Leamington Spa